Attributes | Values |
---|
rdf:type
| |
Description
| - Empirical antifungal therapy is considered to be a standard procedure in high-risk neutropenic patients. Historically, the first antifungals examined in this indication was amphotericin B, with the entry of newer drugs lipid and liposomal amphotericin B, azoles and echinocandins were examined in clinical trials. Despite the uneven design of studies and assessment criteria of effectiveness no substantial differences in the efficacy of individual antifungals were observed, the drugs differed significantly in toxicity. The selection of an appropriate antifungal agent is in the hands of a doctor who is weighing multirange epidemiologiempirická cal, pharmacological and clinical factors for the benefit of every particular patient. In the light of current knowledge and availability of modern diagnostic methods, it is clear that some patients are over-treated when using empirical strategy and therefore it is necessary to confront the strategy of empirical therapy with preemptive approach. (en)
- Empirická antimykotická terapia je považovaná za štandardný postup u rizikových neutropenických pacientov. Historicky bol prvým skúmaným antimykotikom v tejto indikácii amfotericín B, s nástupom novších liekov boli v klinickom skúšaní preverované lipidové a lipozomálne formy amfotericínu, azoly a echinokandíny. Napriek nerovnakému designu štúdií a kritériám hodnotenia efektivity neboli pozorované zásadné rozdiely v účinnosti jednotlivých antimykotík, významne sa lieky líšili v toxicite.
|
Title
| - Empirická antimykotická liečba – história, princípy, vhodné antimykotiká
- Empirical antifungal therapy – history, principles, appropriate antifungals (en)
|
skos:prefLabel
| - Empirická antimykotická liečba – história, princípy, vhodné antimykotiká
- Empirical antifungal therapy – history, principles, appropriate antifungals (en)
|
skos:notation
| - RIV/00216224:14110/10:00051739!RIV12-MSM-14110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216224:14110/10:00051739
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - antifungals; empirical antifungal treatment; empirical treatment (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Múdry, Peter
- Štěrba, Jaroslav
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |
is http://linked.open...avai/riv/vysledek
of | |